Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 51, 102805
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Costs and quality of life in multiple sclerosis patients with spasticityActa Neurologica Scandinavica, 2013
- Risk factors for falls in multiple sclerosis: an observational studyMultiple Sclerosis Journal, 2013
- Spasticity in multiple sclerosis: results of a patient surveyInternational Journal of Neuroscience, 2013
- Comparison of the 2- and 6-minute walk test in multiple sclerosisMultiple Sclerosis Journal, 2011
- Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12)Journal of the Neurological Sciences, 2008
- Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trialClinical Therapeutics, 2008
- Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*Journal of Forensic Sciences, 2008
- Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)Brain, 2005
- Measurement of lower extremity kinematics during level walkingJournal of Orthopaedic Research, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983